PDL BioPharma, Inc.
| Nasdaq: PDLI
PDL BioPharma, Inc. is a biotech company engaged in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies. It has focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Incline Village, NV.